Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
UTHR
UTHR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest UTHR ETF News Today | Earnings, Events & Price Alerts
UTHR News
Ralinepag Phase 3 Study Achieves Key Endpoints
2d ago
Newsfilter
United Therapeutics Drug Clinical Trial Success
1d ago
Benzinga
United Therapeutics Achieves Breakthrough in Drug Study
2d ago
NASDAQ.COM
United Therapeutics Reports Strong Q4 Earnings Exceeding Expectations
5d ago
Benzinga
United Therapeutics' New Drug Plans Pressure Partner and Rival Stocks
6d ago
seekingalpha
MannKind Faces Uncertainty Over Tyvaso DPI Royalties
6d ago
stocktwits
United Therapeutics Q4 2025 Earnings Call Highlights
6d ago
seekingalpha
United Therapeutics Q4 Earnings Beat Expectations
Feb 25 2026
seekingalpha
United Therapeutics Reports Record Financial Results for 2025
Feb 25 2026
Businesswire
United Therapeutics Reports Record 2025 Financial Results
Feb 25 2026
Newsfilter
United Therapeutics Set to Announce Q4 Earnings on February 25
Feb 24 2026
seekingalpha
Tom Gardner Discusses AI and Investment Strategies
Feb 17 2026
Fool
United Therapeutics Reports Positive Phase 1 Results for MiroliverELAP
Jan 26 2026
Benzinga
United Therapeutics Upgraded to Overweight with Price Target of $535.73
Jan 06 2026
Yahoo Finance
WYNN Options Volume Surges 148.3% with 19,101 Contracts Traded
Dec 31 2025
NASDAQ.COM
S&P 500 Futures Steady in Pre-Market Session; United Therapeutics and Intel Underperform
Dec 24 2025
Barron's
Show More News
